News Releases

Bodisen Biotech, Inc. - the First China Based Bio Fertilizer Company Listed on a US Stock Exchange
Monday August 29, 8:30 am ET

Bodisen Releases Fact Sheet

NEW YORK--(BUSINESS WIRE)--Aug. 29, 2005--Bodisen Biotech, Inc. (AMEX: BBC, website: /) announced today that its common stock began trading on the American Stock Exchange under the stock symbol: BBC.

Bodisen provides the following background information about the company:

BODISEN TARGETS A LARGE AND GROWING MARKET IN CHINA

Bodisen is a leading manufacturer of environmentally friendly bio fertilizer products serving the needs of China's 900 million farmers. We engage in research, manufacturing and marketing of proprietary technology based agricultural products targeting China's $17 billion per year fertilizer industry.

BODISEN IS A FAST GROWING AND HIGHLY PROFITABLE COMPANY:

Selected Second Quarter 2005 Results Compared to the Same Period in 2004:

  • Basic earnings per share of $0.18 (fully diluted: $0.17), an increase of 50% for basic earnings per share and 42% for fully diluted;
  • Revenue of $8,416,805, an increase of 99%; Net income of $2,692,014, an increase of 48%;
  • Gross profit of $3,255,664, an increase of 64%

Selected First Half 2005 Results Compared to the Same Period in 2004

  • Revenue of $13,118,480, an increase of 104%
  • Net income of $3,488,746, an increase of 55%
  • Gross profit increased 72% compared to the six month period ended June 30, 2004
  • Basic earnings per share of $0.23 (fully diluted: $0.22), an increase of 53% for basic earnings per share and 47% for fully diluted

BODISEN FACES FAVORABLE MARKET ENVIRONMENT IN CHINA

We are a unique company in a favorable market environment. China exports many things to the world marketplace; however is one of the largest importers of grains and foods in the world. Hundreds of millions of Chinese depend on imported grains to support higher demand for meat and poultry which are fed with imported grains. The Chinese government has mandated that farmers increase crop yields to decrease the nation's dependence on foreign imports. Moreover, there is growing emphasis on the need for "green" fertilizers that restore the soil, rather than deplete it.

BODISEN HAS A FULL LINE OF PRODUCTS THAT EFFECTIVELY ADDRESS COMPLETE PLANTING NEEDS OF CHINESE FARMERS

With over 60 products and approximately 600 national distribution centers and growing, Bodisen has experienced rapid growth in recent years. Bodisen's products are developed by company scientists in collaboration with University laboratories. Our products address grains, vegetables, fruit crops and have been proven to increase yields by 10% to 35% while 100% environmentally friendly. Our products substantially improve the lifestyles of the 900 million Chinese farmers whose livelihood are solely dependent upon their crop yields.

EARNINGS GUIDANCE FOR YEAR 2005

Bodisen affirmed fiscal 2005 (December yearend) guidance for earnings of approximately $8 million (including 1Q05 one time financing related charge), or approximately 50 cents per share, on revenue of approximately $28 million. Guidance does not include positive impact from increased sales channels and further expansion of manufacturing capacities, as a result of the Company's planned dual listing before yearend on the AIM market of the London Stock Exchange raising up to 10 million British Pound (US$18 million) through placement of new shares (Broker: UK investment bank Charles Stanley; Reporting accountant: Deloitte & Touche).

That's us, Bodisen Biotech; we feed the growth of China with environmentally friendly bio fertilizer products. Bodisen's management is focused on increasing shareholder awareness and is pleased by its listing on the American Stock Exchange.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

 

______________________________

Contact:

Bodisen Biotech, Inc.
Investor Relations, 212-566-3503
info@bodisen.com

______________________________

Source: Bodisen Biotech, Inc.

 

Copyright © 2004 bodisen.com